The British journal of dermatology
The most recent articles from:
Br. J. Dermatol.
-
Toxic epidermal necrolysis (TEN) is a severe cutaneous adverse drug reaction with a mortality of 40%. Intravenous immunoglobulin (IVIg) is widely used as a specific treatment for this reaction, although evidence of its benefit is conflicting. ⋯ This study shows that the use of IVIg does not yield survival benefits in SJS/TEN overlap and TEN, even when corrected for IVIg dosages.
-
Letter Case Reports
Novel management of harlequin syndrome with stellate ganglion block.